SOMATULINE AUTOGEL
Google image searchProduct monograph
Active ingredient
lanreotide (lanreotide acetate), 60 MG/SYR
DIN: 02283395
Dosage form(s): SOLUTION (EXTENDED RELEASE)
Route(s) of administration: SUBCUTANEOUS
Description: PRE-FILLED SYRINGE
Schedule: Prescription
Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Date: 16-FEB-2022
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
- H01CB — Antigrowth hormones (ATC, ATC/DDD)
- H01CB03 — LANREOTIDE (ATC/DDD)
Reference brand drug: Somatuline
